openPR Logo
Press release

Endometrial Ablation Market Market Trends and Key Developments 2024

09-19-2017 08:58 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Endometrial Ablation Market Market Trends and Key Developments

TMR estimates that the global market for endometrial ablation will exhibit a promising CAGR of 5.50% from 2016 to 2024, rising from an opportunity worth US$0.8 bn in 2015 to US$1.3 bn by 2024.

Rising Rate of Incidence of Gynecological Diseases to Drive Market

The market is expected to benefit from a number of factors, which will be seen in its steady growth path over the course of the report’s forecast. The key drivers of the market will be factors such as the vast rise in the global prevalence of gynecological disorders, the easy availability of technologically advanced endometrial ablation devices, and high cost of ablation surgeries. The market will also benefit from the rising population of affluent higher middle-class people, especially across emerging economies in regions such as Asia Pacific and Latin America, and the increased expenditure of the world population on advanced healthcare treatments.

View and Download TOC of Endometrial Ablation Market Research Report@ https://www.transparencymarketresearch.com/report-toc/14318

The increased rate of incidence of gynecological conditions such as polycystic ovarian disease (PCOD), abnormal vaginal bleeding, and endometrial and cervical cancers in the past few years has boosted the demand for effective treatments. These factors remain at the helm of the remarkable development achieved by the global endometrial ablation market in the past few years and will continue to lead it towards a healthy growth path in the near future.

Increased Preference to Non-invasive Treatments to Bode Well for Market

Despite having healthy growth prospects in the foreseeable future, the market faces challenges such as issues concerning commercialization in developing and under-developed economies and strict regulatory laws and policies in developed economies. Nevertheless, as the global consumer becomes more educated about the vast benefits of non-invasive treatments, in terms of faster recovery, reduced time in hospitals, and cost of the overall treatment, the market will continue to witness a healthy rise in demand. The vast pool of untapped growth opportunities in emerging economies could also act as a good opportunity for companies aspiring to strengthen their hold on the global endometrial ablation market.

Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14318

North America to Continue to Command Greater Hold on Global Market

In terms of type of devices, the segment of radiofrequency endometrial ablation devices held the dominant share in market’s overall revenue in. The segment is likely to also continue to lead over the report’s forecast period. Factors such as ease of usage, less duration required for surgery, and cost benefits will continue to bode well for the segment over the forecast period, by the end of which the segment is expected to account for a nearly 58% of the overall market. In terms of geography, the market for endometrial ablation in North America is presently the leading contributor in terms of revenue and is likely to retain the top spot throughout the report’s forecast, thanks to the developed healthcare infrastructure. The regional market is projected to hold a nearly 44% of the overall market by 2024.

The presence of a number of large endometrial ablation enterprises such as Cooper Surgical Inc., Medtronic Plc, Boston Scientific Corp., Ethicon Inc., and Hologic Corp., has rendered the vendor landscape of the global endometrial ablation market highly competitive, observes Transparency Market Research in a recent report. To supersede competitors, companies in the market are focusing on growth strategies such as introduction of technologically advanced products and expansion across new regional markets. Owing to these trends, the market has witnessed a vast rise in collaborations, mergers, and acquisitions, leading to a further intensified level of competition.

Buy Full Endometrial Ablation Market Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=14318<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endometrial Ablation Market Market Trends and Key Developments 2024 here

News-ID: 724965 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Endometrial

Rising Prevalence Of Endometrial Cancer Through Advances In The Endometrial Canc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Endometrial Cancer Treatment Industry Market Size Be by 2025? In recent years, the market size for endometrial cancer treatment has experienced consistent growth. It is projected to increase from $31.04 billion in 2024 to $32.09 billion in 2025, indicating a compound annual growth rate (CAGR) of
Rising Prevalence Of Endometrial Cancer Through Advances In The Endometrial Canc …
The Endometrial Cancer Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Endometrial Cancer Treatment Market Size and Projected Growth Rate? The Endometrial Cancer Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to
Endometrial Biopsy Cannulae Market 2023
The report presents detailed information regarding the prominent players and potential competitors in the Endometrial Biopsy Cannulae market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives, and a SWOT analysis. Additionally, the report analyses revenue share and contact details for each player. This comprehensive report aims to evaluate and forecast the market size for Fuel Monitoring Systems. It analyses revenue, growth
Hysteroscopic Endometrial Resection Market - Transforming Hysteroscopy, Enhancin …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Hysteroscopic Endometrial Resection Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Hysteroscopic Endometrial Resection provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes
Endometrial Ablation Market snapshot 2024
Global Endometrial Ablation Market: Snapshot With the rising prevalence of gynecology disorders, such as polycystic ovarian disease (PCOD), abnormal vaginal bleeding, the global adoption of endometrial ablation procedures has increased significantly, leading to an impressive rise in the worldwide endometrial ablation market. Apart from this, the upswing in the incidence rate of cervical and endometrial cancer in women is also driving the growth of this market substantially across the world. Download The
Global Endometrial Ablation Market: Radiofrequency Endometrial Ablation Devices …
With the presence of large players, such as Hologic Corp., Boston Scientific Corp., Cooper Surgical Inc., Ethicon Inc., and Medtronic Plc at the global level, the worldwide market for endometrial ablation demonstrates a highly competitive landscape, finds a new research report by Transparency Market Research (TMR). The market players are focusing aggressively on developing their offerings technologically, which is likely to lead to price differentiation, resulting in intense rivalry between these